“What’s the status of new antibiotic development? Does it need to be encouraged by tax breaks and/or regulatory fast-tracking? “
http://www.tufts.edu/med/apua/news/news-newsletter-vol-30-no-1-2.shtml
In short only two have been approved since 2008. This article details why. (Low hanging scientific fruit has been picked. Not much profit so poor return. Regulations nobody can understand.)
New antibiotic R&D is covered on page 19,057 of OBAMAcare and will commence as soon as funds become available in 2027. Relax and enjoy another beer. //sarc off//